{
    "id": 3484,
    "fullName": "KIT V560del",
    "impact": "deletion",
    "proteinEffect": "gain of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "KIT V560del results in the deletion of an amino acid in the juxtamembrane domain (exon 11) of the Kit protein at amino acid 560 (PMID: 12879016). V560del results in transformation of cultured cells in one study (PMID: 19861435) and therefore, is predicted to lead to a gain of Kit protein function.",
            "references": [
                {
                    "id": 2055,
                    "pubMedId": 12879016,
                    "title": "Signal transduction by several KIT juxtamembrane domain mutations.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/12879016"
                },
                {
                    "id": 670,
                    "pubMedId": 19861435,
                    "title": "Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19861435"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 3815,
        "geneSymbol": "KIT",
        "terms": [
            "KIT",
            "C-Kit",
            "CD117",
            "MASTC",
            "PBT",
            "SCFR"
        ]
    },
    "variant": "V560del",
    "createDate": "03/03/2015",
    "updateDate": "05/14/2019",
    "referenceTranscriptCoordinates": {
        "id": 136864,
        "transcript": "NM_000222",
        "gDna": "chr4:g.54727447_54727449delTTG",
        "cDna": "c.1679_1681delTTG",
        "protein": "p.V560delV",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 4367,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Sutent (sunitinib) inhibited growth of transformed cell lines over expressing KIT V560del in culture (PMID: 19861435).",
            "molecularProfile": {
                "id": 3289,
                "profileName": "KIT V560del"
            },
            "therapy": {
                "id": 930,
                "therapyName": "Sunitinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 670,
                    "pubMedId": 19861435,
                    "title": "Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19861435"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 4366,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Gleevec (imatinib) inhibited growth of transformed cell lines over expressing KIT V560del in culture (PMID: 19861435).",
            "molecularProfile": {
                "id": 3289,
                "profileName": "KIT V560del"
            },
            "therapy": {
                "id": 770,
                "therapyName": "Imatinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 670,
                    "pubMedId": 19861435,
                    "title": "Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19861435"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 6748,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case report, a patient with metastatic thymic carcinoma harboring KIT V560del with KIT over expression initially demonstrated stable disease and reduction in metastatic lesions following treatment with Gleevec (imatinib), but progressed after 6 months (PMID: 15201427).",
            "molecularProfile": {
                "id": 23682,
                "profileName": "KIT V560del KIT over exp"
            },
            "therapy": {
                "id": 770,
                "therapyName": "Imatinib",
                "synonyms": null
            },
            "indication": {
                "id": 3284,
                "name": "thymic carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 5814,
                    "pubMedId": 15201427,
                    "title": "Thymic carcinoma with overexpression of mutated KIT and the response to imatinib.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/15201427"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 11842,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Tasigna (nilotinib) inhibited proliferation of transformed cells expressing a KIT V560del/V654A double mutation in culture (PMID: 17699867).",
            "molecularProfile": {
                "id": 28310,
                "profileName": "KIT V560del KIT V654A"
            },
            "therapy": {
                "id": 829,
                "therapyName": "Nilotinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 676,
                    "pubMedId": 17699867,
                    "title": "Sorafenib inhibits the imatinib-resistant KITT670I gatekeeper mutation in gastrointestinal stromal tumor.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/17699867"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 3289,
            "profileName": "KIT V560del",
            "profileTreatmentApproaches": [
                {
                    "id": 7708,
                    "name": "KIT Inhibitor",
                    "profileName": "KIT V560del"
                }
            ]
        },
        {
            "id": 23682,
            "profileName": "KIT V560del KIT over exp",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 28310,
            "profileName": "KIT V560del KIT V654A",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 136867,
            "transcript": "XM_005265741",
            "gDna": "chr4:g.54727447_54727449delTTG",
            "cDna": "c.1682_1684delTTG",
            "protein": "p.V561delV",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 136868,
            "transcript": "XM_017008179",
            "gDna": "chr4:g.54727456_54727458delTAA",
            "cDna": "c.1679_1681delTAA",
            "protein": "p.I560delI",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 136865,
            "transcript": "NM_001093772",
            "gDna": "chr4:g.54727458_54727460delAAT",
            "cDna": "c.1678_1680delAAT",
            "protein": "p.N560delN",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 136870,
            "transcript": "XM_017008180",
            "gDna": "chr4:g.54727458_54727460delAAT",
            "cDna": "c.1678_1680delAAT",
            "protein": "p.N560delN",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 136864,
            "transcript": "NM_000222",
            "gDna": "chr4:g.54727447_54727449delTTG",
            "cDna": "c.1679_1681delTTG",
            "protein": "p.V560delV",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 136869,
            "transcript": "XM_017008178",
            "gDna": "chr4:g.54727447_54727449delTTG",
            "cDna": "c.1679_1681delTTG",
            "protein": "p.V560delV",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 136871,
            "transcript": "XM_005265742",
            "gDna": "chr4:g.54727456_54727458delTAA",
            "cDna": "c.1679_1681delTAA",
            "protein": "p.I560delI",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 136866,
            "transcript": "XM_005265740",
            "gDna": "chr4:g.54727447_54727449delTTG",
            "cDna": "c.1682_1684delTTG",
            "protein": "p.V561delV",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}